PIK3C3 and autoimmune disease: One potential therapeutic avenue is the activation of Vps34 in Tregs to generate highly potent eTregs in vivo or ex vivo for cellular therapy in autoimmune diseases, as eTregs exhibit greater immunosuppressive function than cTregs [1,2].